| | IGF::OT::IGF | CANGENE CORPORATION | $452,864 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325412Pharmaceutical Preparation Manufacturing | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 6, 2018 | Aug 29, 2018 | Jul 31, 2025 |
| | VARIZIG | CANGENE CORPORATION | $3,495 | VETERANS AFFAIRS, DEPARTMENT OF | VETERANS AFFAIRS, DEPARTMENT OF | — | 325412Pharmaceutical Preparation Manufacturing | 6505DRUGS AND BIOLOGICALS | Oct 7, 2014 | Oct 7, 2014 | Feb 28, 2015 |
| | IGF::OT::IGF | CANGENE CORPORATION | $63,304,735 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325412Pharmaceutical Preparation Manufacturing | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 16, 2013 | Sep 16, 2013 | Sep 8, 2018 |
| | IGF::OT::IGF VACCINIA IMMUNE GLOBULIN (VIG) SMALLPOX | CANGENE CORPORATION | $102,035,440 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 325414Biological Product (except Diagnostic) Manufacturing | Q301MEDICAL- LABORATORY TESTING | Sep 1, 2012 | Aug 9, 2012 | Aug 9, 2017 |
| | HEPTAVALENT EQUINE BOTULISM ANTITOXIN | CANGENE CORPORATION | $576,641 | DEPT OF THE ARMY | DEPT OF THE ARMY | — | 541711 | 6640LABORATORY EQUIPMENT AND SUPPLIES | May 31, 2012 | May 31, 2012 | Aug 17, 2012 |
| | HE-BAT CANGENE BB IND #12502 | CANGENE CORPORATION | $407,500 | DEPT OF THE ARMY | DEPT OF THE ARMY | — | 325414Biological Product (except Diagnostic) Manufacturing | 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | Aug 26, 2009 | Aug 25, 2009 | Jun 15, 2011 |
| | DRUGS AND BIOLOGICALS | CANGENE CORPORATION | $1,561,865 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325414Biological Product (except Diagnostic) Manufacturing | 6505DRUGS AND BIOLOGICALS | Jun 16, 2006 | Jun 16, 2006 | Sep 28, 2018 |
| | TAS::75 XXXX::TAS | CANGENE CORPORATION | $594,219,525 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325414Biological Product (except Diagnostic) Manufacturing | 6505DRUGS AND BIOLOGICALS | May 30, 2006 | May 30, 2006 | Dec 31, 2027 |
| | ANTHRAX THERAPEUTICS | CANGENE CORPORATION | $160,848,139 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325412Pharmaceutical Preparation Manufacturing | 6505DRUGS AND BIOLOGICALS | Sep 23, 2005 | Sep 27, 2005 | Sep 30, 2023 |
| | — | CANGENE CORPORATION | $0 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541990All Other Professional, Scientific, and Technical Services | R499SUPPORT- PROFESSIONAL: OTHER | Sep 15, 2003 | Sep 15, 2003 | Oct 31, 2007 |
| | 01010 CANGENE | CANGENE CORPORATION | $329,170,241 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 621511Medical Laboratories | — | Jan 23, 2003 | Jan 23, 2003 | Jul 21, 2015 |
| | CANGENE, 200-2002-00357 | CANGENE CORPORATION | $40,599,750 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 621511Medical Laboratories | — | Jan 23, 2003 | Jan 23, 2003 | Aug 9, 2007 |
| | CANGENE, 200-2002-00357 | CANGENE CORPORATION | $40,599,750 | CENTERS FOR DISEASE CONTROL AND PREVENTION | CENTERS FOR DISEASE CONTROL AND PREVENTION | — | 621511Medical Laboratories | — | Sep 11, 2002 | Sep 11, 2002 | Aug 9, 2007 |